In the CEBPAbZIP AML cohort, KMT2CMUT AML were more likely to have co‐mutations of NRAS (50.0% vs. 21.1%, p = .05) than KMT2CWT. The gene discussed is NRAS; the disease is acute myeloid leukemia.